I agree that this site is using cookies. You can find further informations here.
X
Thirman, Michael J.
93  results:
Search for persons X
?
1

Long‐term follow‐up of VIALE‐A: Venetoclax and azacitidine ..:

Pratz, Keith W. ; Jonas, Brian A. ; Pullarkat, Vinod...
American Journal of Hematology.  99 (2024)  4 - p. 615-624 , 2024
Link: https://doi.org/10.1002/..
 
?
2

The menin inhibitor revumenib in KMT2A-rearranged or NPM1-m..:

Issa, Ghayas C. ; Aldoss, Ibrahim ; DiPersio, John...
Nature.  615 (2023)  7954 - p. 920-924 , 2023
Link: https://doi.org/10.1038/..
 
?
3

P525: LONG-TERM OUTCOMES OF STEM CELL TRANSPLANT IN OLDER P..:

Pratz, Keith ; Dinardo, Courtney ; L Arellano, Martha...
HemaSphere.  7 (2023)  S3 - p. e68978fe , 2023
Link: https://doi.org/10.1097/..
 
?
4

Clinical and molecular response of acute myeloid leukemia h..:

Roloff, Gregory W. ; Wen, Frank ; Ramsland, Aubrianna...
Haematologica.  108 (2023)  8 - p. 2234-2239 , 2023
Link: https://doi.org/10.3324/..
 
?
5

Socioeconomic determinants of the biology and outcomes of a..:

Johnston, Hannah ; Youshanlouei, Hamed Rahmani ; Osei, Clinton...
Blood Advances.  8 (2023)  1 - p. 164-171 , 2023
Link: https://doi.org/10.1182/..
 
?
6

Impact of FLT3 Mutation on Outcomes after Venetoclax and Az..:

Konopleva, Marina ; Thirman, Michael J. ; Pratz, Keith W....
Clinical Cancer Research.  28 (2022)  13 - p. 2744-2752 , 2022
Link: https://doi.org/10.1158/..
 
?
7

Efficacy and tolerability of a modified pediatric‐inspired ..:

Patel, Anand Ashwin ; Heng, Joseph ; Dworkin, Emily...
eJHaem.  2 (2021)  3 - p. 413-420 , 2021
Link: https://doi.org/10.1002/..
 
?
8

Venetoclax with azacitidine or decitabine in patients with ..:

Pollyea, Daniel A. ; Pratz, Keith ; Letai, Anthony...
American Journal of Hematology.  96 (2020)  2 - p. 208-217 , 2020
Link: https://doi.org/10.1002/..
 
?
9

MPN-288: Molecular Characteristics of IDH2-Mutated, Philade..:

Patel, Anand ; Cahill, Kirk ; Charnot-Katsikas, Angella...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S335-S336 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negativ..:

Patel, Anand A. ; Cahill, Kirk ; Charnot‐Katsikas, Angella...
British Journal of Haematology.  190 (2020)  1 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
11

A phase 1 study of azacitidine with high-dose cytarabine an..:

Odenike, Olatoyosi ; Stock, Wendy ; Larson, Richard A....
Blood Advances.  4 (2020)  4 - p. 599-606 , 2020
Link: https://doi.org/10.1182/..
 
?
12

AML-063: A Randomized, Double-Blind, Placebo-Controlled Stu..:

DiNardo, Courtney D. ; Jonas, Brian A. ; Pullarkat, Vinod...
Clinical Lymphoma Myeloma and Leukemia.  20 (2020)  - p. S179 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Entospletinib monotherapy in patients with relapsed or refr..:

Awan, Farrukh T. ; Thirman, Michael J. ; Patel-Donnelly, Dipti...
Leukemia & Lymphoma.  60 (2019)  8 - p. 1972-1977 , 2019
Link: https://doi.org/10.1080/..
 
?
14

Lenalidomide consolidation benefits patients with CLL recei..:

Byrd, John C. ; Ruppert, Amy S. ; Heerema, Nyla A....
Blood Advances.  2 (2018)  14 - p. 1705-1718 , 2018
Link: https://doi.org/10.1182/..
 
?
15

A phase I study of selinexor in combination with high-dose ..:

Wang, Amy Y. ; Weiner, Howard ; Green, Margaret...
Journal of Hematology & Oncology.  11 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
1-15